Literature DB >> 6609102

Oesophageal stricture and dysphagia after endoscopic sclerotherapy for bleeding varices.

T Sørensen, F Burcharth, M L Pedersen, F Findahl.   

Abstract

Oesophageal stricture and dysphagia after endoscopic sclerotherapy of oesophageal varices were assessed with regard to occurrence and severity and the relation to the treatment. We followed 34 patients for three to 47 months who had two to 25 treatments with submucosal, paravenous injections of polidocanol (3%). Twenty patients (59%) developed stricture or dysphagia; 14 both dysphagia and endoscopically verified stricture, two dysphagia without stricture, and four stricture without dysphagia. Both phenomena occurred intermittently and often independent of each other, but occupied median 38% of the observation time in these 20 patients. The patients developing strictures had received significantly more treatments and greater amount of sclerosant, and they had significantly more preceding mucosal necroses. The varices were eradicated to about the same degree and the incidence of recurrent haemorrhage was the same as in the patients who had not developed stricture.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609102      PMCID: PMC1432468          DOI: 10.1136/gut.25.5.473

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  The natural history of cirrhosis. I. Survival with esophageal varices.

Authors:  A J GARCEAU; T C CHALMERS
Journal:  N Engl J Med       Date:  1963-02-28       Impact factor: 91.245

2.  A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices.

Authors:  G W Johnston; H W Rodgers
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

3.  Oesophageal function in cirrhotic patients undergoing injection sclerotherapy for oesophageal varices.

Authors:  S J Ogle; C J Kirk; R J Bailey; A G Johnson; R Williams; I M Murray-Lyon
Journal:  Digestion       Date:  1978       Impact factor: 3.216

4.  Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial.

Authors:  B R MacDougall; D Westaby; A Theodossi; J L Dawson; R Williams
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

5.  The complications of injection sclerotherapy of bleeding oesophageal varices.

Authors:  M S Barsoum; H Abdel-Wahab Mooro; F I Bolous; A F Ramzy; M A Rizk-Allah; F I Mahmoud
Journal:  Br J Surg       Date:  1982-02       Impact factor: 6.939

6.  Oesophageal varices treated by sclerotherapy: a histopathological study.

Authors:  D M Evans; D B Jones; B K Cleary; P M Smith
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

7.  Esophageal function after sclerotherapy of bleeding varices.

Authors:  T Sauerbruch; R Wirsching; B Leisner; M Weinzierl; M Pfahler; G Paumgartner
Journal:  Scand J Gastroenterol       Date:  1982-09       Impact factor: 2.423

8.  A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding.

Authors:  J Terblanche; J M Northover; P Bornman; D Kahn; W Silber; G O Barbezat; S Sellars; J A Campbell; S J Saunders
Journal:  Surg Gynecol Obstet       Date:  1979-03

9.  Prospective controlled trial of injection sclerotherapy in patient with cirrhosis and recent variceal haemorrhage.

Authors:  A W Clark; B R Macdougall; D Westaby; K J Mitchell; D B Silk; L Strunin; J L Dawson; R Williams
Journal:  Lancet       Date:  1980-09-13       Impact factor: 79.321

10.  Sclerotherapy of bleeding oesophageal varices by means of endoscopy.

Authors:  K J Paquet; E Oberhammer
Journal:  Endoscopy       Date:  1978-02       Impact factor: 10.093

  10 in total
  17 in total

Review 1.  Complications and hazards of gastrointestinal endoscopy.

Authors:  A Habr-Gama; J D Waye
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

2.  A newly-designed shape-memory coil stent for esophageal stricture: a preliminary report.

Authors:  S Tamura; M Hirao; H Shiozaki; M Inoue; T Hashimoto; S Hori; I Ohkata; H Asano; M Monden
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Endoscopic sclerotherapy in porcine esophagus changes luminal cross-sectional area and wall distensibility dose- and time-dependently.

Authors:  J A Petersen; C Djurhuus; J Koff; L Vinter-Jensen; H Gregersen
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

Review 4.  Prophylactic sclerotherapy for varices.

Authors:  D W Bullimore; P Foster
Journal:  BMJ       Date:  1988-08-06

5.  BENIGN STRICTURES OF THE GASTROINTESTINAL TRACT.

Authors:  A C Anand; S P Kalra
Journal:  Med J Armed Forces India       Date:  2017-06-26

6.  Oesophageal stricture after endoscopic sclerotherapy.

Authors:  T McCormack; A G Johnson
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

7.  Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial.

Authors:  S K Sarin; R Nanda; G Sachdev; S Chari; B S Anand; S L Broor
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

8.  Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs.

Authors:  C O Juhl; L Vinter-Jensen; L S Jensen; E Nexø; J C Djurhuus; E Z Dajani
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

Review 9.  Complications and limitations of injection sclerotherapy in portal hypertension.

Authors:  N D Heaton; E R Howard
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

10.  Recombinant human epidermal growth factor prevents sclerotherapy-induced esophageal ulcer and stricture formations in pigs.

Authors:  C O Juhl; L S Jensen; T Steiniche; E Moussa
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.